For decades, the story of Alzheimer's research has been dominated by a battle between A-beta and tau amyloids, both of which ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Semaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through ...

Previous studies have concluded that early intervention in dementia cases can increase patients' treatment options and ...

Eli Lilly and Company’s LLY stock has declined 15.7% in the past year. The first-quarter earnings miss, guidance cut and some ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.

GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...